Orphazyme Aps

Developer of therapeutics for the treatment of rare and genetic diseases

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2009 groups141 employees language orphazyme.com

Registered entities

Investor mix

11 investors on record; lead investors include Kurma Partners, Life Sciences Partners, ALS Investment Fund; 1 has since exited.

Investor typeCountShare
Venture capital436%
Private equity436%
Accelerator & incubator19%
Bank & private debt19%
Other / undisclosed19%
Coming soon